Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Short-Term Debt issuances (2016 - 2026)

Kewaunee Scientific (KEQU) has 14 years of Short-Term Debt issuances data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Short-Term Debt issuances fell 92.28% year-over-year to $2.0 million; the TTM value through Oct 2025 reached $12.7 million, down 90.44%, while the annual FY2025 figure was $73.5 million, 50.37% down from the prior year.
  • Short-Term Debt issuances reached $2.0 million in Q4 2025 per KEQU's latest filing, up from $1.4 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $40.6 million in Q3 2023 and bottomed at $1.3 million in Q2 2025.
  • Average Short-Term Debt issuances over 5 years is $19.4 million, with a median of $16.3 million recorded in 2021.
  • Peak YoY movement for Short-Term Debt issuances: surged 816.2% in 2023, then plummeted 96.42% in 2025.
  • A 5-year view of Short-Term Debt issuances shows it stood at $16.3 million in 2021, then crashed by 72.88% to $4.4 million in 2022, then soared by 769.31% to $38.5 million in 2023, then plummeted by 33.44% to $25.6 million in 2024, then tumbled by 92.28% to $2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short-Term Debt issuances were $2.0 million in Q4 2025, $1.4 million in Q3 2025, and $1.3 million in Q2 2025.